ePI on FHIR: Shaping the Future of Global Healthcare – Part 2
Gravitate Health and FIFARMA, which represents research‑based pharmaceutical companies and associations across Latin America and the Caribbean, shared the latest perspectives on electronic Product Information (ePI) and digital health.
Following introductions by Mrs Ronnie Mundair, (Pfizer, Gravitate-Health) and Mrs Yaneth Giha (FIFARMA), Mr Diego Salas (FIFARMA), presented the LatAm Playbook for Electronic Product Information (ePI) Implementation. FIFARMA, together with EFPIA, developed the Playbook to fulfil their objective: promote innovative ecosystems and policies that support the strengthening of sustainable health systems of the Latin American countries and advance towards better health in the region.
Among the speakers, Prof. Anne Moen, Academic Coordinator, University of Oslo, briefly presented Gravitate-Health at this final phase of the project. Dr. Erol Hofmans (MEB – Gravitate-Health) talked about the perspective of the Medicines Evaluation Board -The Netherlands National Competent Authority- on advancing the national ePI journey through Gravitate Health. Mr Craig Anderson, Business Product Director for Labeling, Johnson & Johnson focused on FHIR ePI -through a more technical approach- and the impact on global digital labeling strategies. The session’s closing remarks addressed Mr Leonardo Semprun (MSD & FIFARMA).
View the LatAm Playbook for ePI Implementation:
Key takeaways from this session
- Trusted medicine information should be available in digital health environments.
- Developing ePI requires strong collaboration between regulators and stakeholders.
- Successful implementation depends on integration with national health systems.
RECORDING is available
If you missed the session, you can view the recording, as well as the speakers’ presentations, here:
agenda
- Welcome, Agenda & Introductions – Mrs Ronnie Mundair, Senior Director, GRS, Pfizer
- Strengthening FIFARMA’s commitment to healthcare – Mrs Yaneth Giha, Executive Director, FIFARMA
- LATAM ePI Playbook – Mr Diego Salas, Director, FIFARMA
- An update from Gravitate-Health – Prof. Anne Moen, Academic Coordinator, University of Oslo
- Advancing the National ePI Journey through Gravitate Health: An NCA perspective – Dr Erol Hofmans, Innovation Advisor, MEB
- FHIR ePI and the impact on global digital labeling strategies – Mr Craig Anderson, Business Product Director, J&J
- Closing Remarks – Mr Leonardo Semprun, Global Regulatory Policy Lead LatAm MSD & FIFARMA Regulatory Group Co-Chair
AGENDA & TOPICS
- General introductions and a Summary of key ePI global developments, Rie Matsui, APAC e-labeling EWG leader; Senior Director and Regional Labeling Head for APAC, Pfizer R&D Japan, & Anne Moen, Coordinator, Gravitate Health; Professor, University of Oslo, Norway
- Introduction to Gravitate Health, Giovanna Ferrari, Project Lead, Gravitate Health; Senior Director and Regional Labeling Head, Pfizer
- EMA – a regulators’ perspective (EU) and lessons learned from ePI pilot, Elizabeth Scanlan, ePI Product Owner, European Medicines Agency
- Jordan – a regulators’ perspective (Middle East) and demo of ePI system/app, Mohd. Rabi, IT Specialist, Drug Directorate, JFDA
- Taiwan – a regulator’s perspective (APAC) and future plans for e-labeling introduction, Chi Chung, Section Chief, TFDA
- Compendia – Felleskatalogen’s 20-year journey towards electronic product information (ePI) in Norway, Bente By Jansen, Managing director, Felleskatalogen AS
Panel Discussion & Q&A
The event concluded with a panel discussion, where attendees engaged with the speakers and asked questions about ePI’s potential in transforming global healthcare systems.
EVENT HIGHLIGHTS
WHEN? March 18, 2026
Time:
16:00 – 17:30 CET | 12:00 – 13:30 BRT – Brazil | 10:00 – 11:30 COT – Colombia | 09:00 – 10:30 CST – Mexico City
WHERE? Virtual
ePI is on FHIR around the Globe – Part 1
This joint event builds on the insights from Gravitate Health’s first virtual event “ePI is on FHIR around the Globe” held in October 2024, and was co-hosted with the Asia Partnership Conference of Pharmaceutical Associations (APAC).
Find out more on this successful event attended by about 600 participants, which featured a distinguished panel of speakers from various regions—with emphasis in the Middle East, and Asia—and Europe.
